Atara Biotherapeutics Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Atara Biotherapeutics is a biotechnology company focused on allogeneic T-cell immunotherapies that aim to provide off-the-shelf treatment options for patients with serious diseases. The company's platform centers on Epstein-Barr virus–targeted T cells, enabling therapies that address EBV-associated diseases and other serious conditions without requiring TCR or HLA gene editing. Its lead program has achieved marketing authorization in Europe, and its pipeline includes tab-cel for EBV-positive post-transplant lymphoproliferative disease and ATA188 for potential use in multiple sclerosis, alongside next-generation CAR-T candidates for solid tumors and hematologic malignancies. Headquartered in Thousand Oaks, California, the company operates in the biotechnology research sector with a mid-sized workforce. Its therapies are designed to serve patients with solid tumors, blood cancers, and autoimmune diseases by offering off-the-shelf cellular treatments that address high unmet medical needs. In June 2026, Atara announced the appointment of Brian Cherry to its board of directors, a governance development.
1-888-653-2347 
support@leadiq.com 
